Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Subcutaneous administration provides the appropriate absorption rate for this peptide
Women with PCOS face a 2.8-fold higher risk for obesity and a 1.7-fold higher risk for central obesity compared with individuals without PCOS ( AOMs, including liraglutide and semaglutide, combined with lifestyle intervention could offer an upgraded treatment strategy for patients with PCOS and obesity (32)
The dose may be increased slowly over time, depending on how the patient responds and whether there are any side effects
the product is sterile, non-pyrogenic, with pH 4.57.0 per manufacturing specification
US$ 22.69
:format(webp))
US$ 25.73
US$ 22.67
US$ 29.70
US$ 26.70
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
